Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Randomized Study to Evaluate the Efficacy and Safety of TAK-475 or Placebo When Coadministered With Fenofibrate in Subjects With Combined Hyperlipidemia

NCT00813527 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT00813527
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00813527 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Randomized Study to Evaluate the Efficacy and Safety of TAK-475 or Placebo When Coadministered With Fenofibrate in Subjects With Combined Hyperlipidemia
Lead sponsor
Takeda
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2006
Completion date
January 31, 2007
Enrollment
213 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

hyperlipidemias